XML 59 R51.htm IDEA: XBRL DOCUMENT v3.25.2
Long-term investments - Income Statement (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Schedule of Investments [Line Items]        
Revenue $ 12,498 $ 14,109 $ 19,821 $ 28,537
Gross profit 842 2,359 2,377 1,817
Operating expenses:        
Research and development 1,574 3,460 2,867 7,809
General and administrative 4,106 5,720 6,778 12,915
Sales and marketing 290 962 733 2,083
Foreign exchange gain (4,224) (141) (5,427) 1,795
Depreciation and amortization 106 98 214 456
Operating expenses 1,852 10,099 5,165 25,058
Loss from continuing operations (1,010) (7,740) (2,788) (23,241)
Interest income, net of bank charges (147) 95 502 21
Income (loss) before income taxes (5,009) 4,231 (10,214) (11,659)
Income tax (recovery) expense 44 85 134 216
Net income (loss) for the period (34,344) 5,817 (36,795) (7,831)
Cespira Joint Venture        
Schedule of Investments [Line Items]        
Revenue 12,020 4,059 28,819 4,059
Cost of revenue 13,946 3,901 30,230 3,901
Gross profit (1,926) 158 (1,411) 158
Operating expenses:        
Research and development 1,888 1,121 4,890 1,121
General and administrative 2,692 715 5,419 715
Sales and marketing 322 69 618 69
Foreign exchange gain (845) 0 (88) 0
Depreciation and amortization 860 265 1,590 265
Operating expenses 4,917 2,170 12,429 2,170
Loss from continuing operations (6,843) (2,012) (13,840) (2,012)
Interest income, net of bank charges 25 0 32 0
Income (loss) before income taxes (6,818) (2,012) (13,808) (2,012)
Income tax (recovery) expense (72) 4 (64) 4
Net income (loss) for the period $ (6,746) $ (2,016) $ (13,744) $ (2,016)